Wed, March 5, 2025
[ Wed, Mar 05th 2025 ]: Mint
How India's youngest pension fund gamed a falling market to outdo its older rivals
[ Wed, Mar 05th 2025 ]: WOPRAI
120 Earnings Releases for Mar 05th, 2025
[ Wed, Mar 05th 2025 ]: cnbctv18
Apollo Hospitals to invest ?250 crore in India's first Proteus One proton therapy system
Tue, March 4, 2025
[ Tue, Mar 04th 2025 ]: Reuters
Europe's Defence Stocks Extend Rally as Trump Pauses Military Aid to Ukraine
[ Tue, Mar 04th 2025 ]: Reuters
Investors say it's time to take Trump seriously as markets recoil on wall of tariffs
[ Tue, Mar 04th 2025 ]: Crypto
Dave Ramsey warns on crypto, stick to 401(k)s and Roth IRA
[ Tue, Mar 04th 2025 ]: Forbes
Financial Literacy Lessons From 5 Past Oscars Movies
[ Tue, Mar 04th 2025 ]: bnnbloomberg
JPMorgan traders turn glum on U.S. stocks, expecting tariff pain
[ Tue, Mar 04th 2025 ]: MarketWatch
What 125 years of data says about diversification and investing at record highs
[ Tue, Mar 04th 2025 ]: AOL
If you'd invested $1,000 at Microsoft's IPO, here's how much you'd have now
[ Tue, Mar 04th 2025 ]: MSN
Top 100 Stocks to Buy: Coastal Financial Jumps Into the Top 20. Time to Buy?
[ Tue, Mar 04th 2025 ]: Investing
US stocks slump, continuing the tariff-driven selloff
[ Tue, Mar 04th 2025 ]: Reuters
Stocks drop as Trump says tariffs start Tuesday; euro gains
[ Tue, Mar 04th 2025 ]: MSN
What Drives Nvidia's Growth?
[ Tue, Mar 04th 2025 ]: Forbes
Experts Explain How To Invest In Stocks With 11 Simple Tips
[ Tue, Mar 04th 2025 ]: MSN
Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street's Bullish Views?
[ Tue, Mar 04th 2025 ]: MSN
Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4
[ Tue, Mar 04th 2025 ]: GOBankingRates
2 Reasons Meta Stock Broke Its Winning Streak: Should You Still Invest?
[ Tue, Mar 04th 2025 ]: MSN
Cash ISAs won't be axed but saving limits may be reduced, minister hints
[ Tue, Mar 04th 2025 ]: GOBankingRates
4 Stocks That Soared During Biden's Presidency
[ Tue, Mar 04th 2025 ]: MSN
Worried About the Market? Here's How Warren Buffe .. , and Harvard University Protect Their Portfolios
[ Tue, Mar 04th 2025 ]: Investing
Asia stocks drop tracking Wall Street's plunge after Trump's tariff decision
[ Tue, Mar 04th 2025 ]: MSN
Morgan Stanley Raises Nvidia (NVDA) Price Target: Is the Stock Positioned for Further Growth?
[ Tue, Mar 04th 2025 ]: MSN
Is the S&P 500 Ready to Rally? A $1.8M Bet on SPY Says Yes
[ Tue, Mar 04th 2025 ]: MSN
3 Dividend Stock ETFs to Buy With $2,000 and Hold Forever
[ Tue, Mar 04th 2025 ]: AOL
Better Artificial Intelligence (AI) Stock: Broadcom vs. Nvidia Stock
[ Tue, Mar 04th 2025 ]: MSN
Elastic N.V. (ESTC): Surpassing Expectations with GenAI and Cloud Solutions
[ Tue, Mar 04th 2025 ]: MSN
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) .. nd The Rest Of The Branded Pharmaceuticals Stocks
[ Tue, Mar 04th 2025 ]: ThePrint
PrimeAurora Review 2025: Legit Or Scam Trading Platform? - Unveiling Facts!
[ Tue, Mar 04th 2025 ]: Forbes
How To Get Rich With These Money Secrets
[ Tue, Mar 04th 2025 ]: Reuters
Analysis-Investors Say It's Time to Take Trump Seriously as Markets Recoil
[ Tue, Mar 04th 2025 ]: MSN
Hyperscale Data, Inc. (GPUS) Shifts Focus to AI D .. rs, Reports $150.4M in Pro Forma Revenue for 2024
[ Tue, Mar 04th 2025 ]: Reuters
US Stocks Face Tricky Moment as Trump's Latest Tariffs Loom
[ Tue, Mar 04th 2025 ]: MSN
Why Brainchip, Lottery Corp, Qantas, and Transurban shares are pushing higher
[ Tue, Mar 04th 2025 ]: WOPRAI
As of Mar 04th, 2025, there has been substantial .. ng of GameSquare Holdings, Inc. in recent trading
[ Tue, Mar 04th 2025 ]: WOPRAI
As of Mar 04th, 2025, there has been substantial selling of Azitra, Inc. in recent trading
[ Tue, Mar 04th 2025 ]: WOPRAI
As of Mar 04th, 2025, there has been substantial .. elling of Immix Biopharma, Inc. in recent trading
[ Tue, Mar 04th 2025 ]: WOPRAI
As of Mar 04th, 2025, there has been substantial .. ng of VS MEDIA Holdings Limited in recent trading
[ Tue, Mar 04th 2025 ]: WOPRAI
As of Mar 04th, 2025, there has been substantial selling of Africa Oil Corp. in recent trading
[ Tue, Mar 04th 2025 ]: WOPRAI
As of Mar 04th, 2025, there has been substantial .. termap Technologies Corporation in recent trading
[ Tue, Mar 04th 2025 ]: WOPRAI
As of Mar 04th, 2025, there has been substantial .. elling of Piedmont Lithium Inc. in recent trading
[ Tue, Mar 04th 2025 ]: WOPRAI
As of Mar 04th, 2025, there has been substantial .. g of Opendoor Technologies Inc. in recent trading
[ Tue, Mar 04th 2025 ]: WOPRAI
As of Mar 04th, 2025, there has been substantial .. ling of Gencor Industries, Inc. in recent trading
[ Tue, Mar 04th 2025 ]: WOPRAI
As of Mar 04th, 2025, there has been substantial .. Zentalis Pharmaceuticals, Inc. in recent trading
[ Tue, Mar 04th 2025 ]: WOPRAI
As of Mar 04th, 2025, there has been substantial selling of Auna SA in recent trading
[ Tue, Mar 04th 2025 ]: WOPRAI
As of Mar 04th, 2025, there has been substantial selling of Galecto, Inc. in recent trading
[ Tue, Mar 04th 2025 ]: WOPRAI
As of Mar 04th, 2025, there has been substantial .. Therapeutics, Inc. Common stock in recent trading
[ Tue, Mar 04th 2025 ]: WOPRAI
As of Mar 04th, 2025, there has been substantial .. ling of Aptose Biosciences Inc. in recent trading

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

The article from MSN Money discusses the performance and potential of Sarepta Therapeutics (SRPT) and other therapeutics stocks in the fourth quarter. It highlights how Sarepta Therapeutics, a company focused on developing treatments for rare diseases, has shown significant promise with its gene therapy and RNA-based treatments for Duchenne muscular dystrophy. The piece notes that despite the high-risk nature of biotech investments, Sarepta has managed to attract investor interest due to its innovative pipeline and recent FDA approvals. The article also touches on broader market trends, suggesting that therapeutics stocks could be winners in Q4 due to advancements in medical research, regulatory successes, and the ongoing demand for new treatments. It advises investors to look for companies with strong fundamentals, upcoming catalysts like FDA decisions, and robust clinical trial results, positioning Sarepta as a notable example in this sector.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/savingandinvesting/spotting-winners-sarepta-therapeutics-nasdaq-srpt-and-therapeutics-stocks-in-q4/ar-AA1Adomy ]